ICU Management & Practice, ICU Volume 7 - Issue 2 - Summer 2007

www.arrowintl.com

 

On October 1st, 2006 Arrow International received CE mark clearance for its ARROWg+ard Blue PLUS new catheter generation with Chlorhexidine along the entire intraluminal path and increased levels of Chlorhexidine on the catheter's external surface for better protection. Chlorhexidine-silver sulfadiazine is a CDC level 1B recommendation for the prevention of infection, for implementation and is supported by experimental, clinical and epidemiological studies.

«« New ‘Robust’ Treatment for Stroke Uses Genetic Material From Bone Marrow


Your Eyes May Hold Clues to Stroke Risk »»